ROI on Webinars and Online Events for Doctors
Dive deeper to understand the ROI on Webinars and Online Events Globally, doctors are a busy tribe and getting them involved in any offline activity is becoming challenging every day. The COVID-19 pandemic has made it even harder. Time is a resource which is scarce and valued highly by busy medical professionals. Make no mistake,…
HCP Preference on Effectiveness of COVID-19 Vaccine
Objective: Need to Understand HCP Perception of COVID-19 Vaccine As soon as the COVID-19 outbreak was declared a pandemic, research and studies began on developing a vaccine for the pandemic. It is believed that vaccination against COVID-19 will protect most of the population and help achieve ‘Herd Immunity’. Recently, we conducted a community survey, to…
Neoadjuvant Chemotherapy and Ipilimumab For Stage II-IIIA Non-Small Cell Lung Cancer
Objective of this Therapy Area Insight Immune therapy is increasingly becoming an effective treatment for non-small cell lung cancer (NSCLC). The Objective of this study is to determine the percentage of early stage NSCLC patients with detectable circulating T cells specific against tumor-associated antigen (TAA) after receiving platinum based neoadjuvant chemotherapy plus ipilimumab before surgery.…
What Doctors Expect from an Impactful Webinar
Companies worldwide have accelerated their digital transformation by adopting webinars in a big way for HCP engagement. The challenge however is that almost every player is doing it.
Can Pharma marketers create impact in a crowded webinar space? The answer is to differentiate well and execute effectively.
